内容很干货
期待内容的多样性，基层医疗的福音
Description
1、诊宝倍是特色疗法输出产品，为基层诊所提供安全、高效、特色的诊疗方案。
2、符合基层诊所的患者类型、诊疗特点；
3、解读国内外前沿的诊疗指南，吸收传统医学的治疗优势；
4、打通专家和基层诊所的沟通与互动通道；
5、专业医护全程协助
(免责声明：用户在使用此应用之前以及做出任何医疗决定之前，请寻求医生的建议)
2、符合基层诊所的患者类型、诊疗特点；
3、解读国内外前沿的诊疗指南，吸收传统医学的治疗优势；
4、打通专家和基层诊所的沟通与互动通道；
5、专业医护全程协助
(免责声明：用户在使用此应用之前以及做出任何医疗决定之前，请寻求医生的建议)
Screenshots
诊教授 FAQ
-
Is 诊教授 free?
Yes, 诊教授 is completely free and it doesn't have any in-app purchases or subscriptions.
-
Is 诊教授 legit?
Not enough reviews to make a reliable assessment. The app needs more user feedback.
Thanks for the vote -
How much does 诊教授 cost?
诊教授 is free.
-
What is 诊教授 revenue?
To get estimated revenue of 诊教授 app and other AppStore insights you can sign up to AppTail Mobile Analytics Platform.
User Rating
App is not rated in Belgium yet.
Ratings History
诊教授 Reviews
Store Rankings
Ranking History
App Ranking History not available yet
Category Rankings
App is not ranked yet
诊教授 Installs
Last 30 days
诊教授 Revenue
Last 30 days诊教授 Revenue and Downloads
Gain valuable insights into 诊教授 performance with our analytics.
Sign up now to access downloads, revenue, and more.
Sign up now to access downloads, revenue, and more.
App Info
- Category
- Medical
- Publisher
- 四川欣佳能达医药有限公司
- Languages
- Arabic, English, French, German, Indonesian, Italian, Japanese, Korean, Malay, Portuguese, Russian, Chinese, Spanish, Thai, Chinese, Turkish, Vietnamese
- Recent release
- 3.5.0 (1 month ago )
- Released on
- Sep 21, 2020 (4 years ago )
- Also available in
- China, Poland, Italy, Japan, South Korea, Kuwait, Kazakhstan, Lebanon, Mexico, Malaysia, Nigeria, Netherlands, Norway, New Zealand, Peru, Philippines, Pakistan, India, Portugal, Romania, Russia, Saudi Arabia, Sweden, Singapore, Thailand, Türkiye, Taiwan, Ukraine, United States, Vietnam, South Africa, Dominican Republic, Argentina, Austria, Australia, Azerbaijan, Belgium, Brazil, Belarus, Canada, Switzerland, Chile, Colombia, Czechia, Germany, Denmark, United Arab Emirates, Algeria, Ecuador, Egypt, Spain, Finland, France, United Kingdom, Greece, Hong Kong SAR China, Hungary, Indonesia, Ireland, Israel
- Last Updated
- 2 months ago